Evidence map›Paper›PMID 32378380›Full record

ReviewCroatian medical journal2020

How to face the aging world - lessons from dementia research.

Dinko Mitrečić, Dražen Juraj Petrović, Paula Stančin, Jasmina Isaković, Barbara Zavan, Gerardo Tricarico, Mirjana Kujundžić Tiljak, Monica Di Luca

Abstract readReview
In one paragraph

Review in Croatian medical journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dinko MitrečićDinko Mitrečić, Laboratory for Stem Cells, Croatian Institute for Brain Research, Department of Histology and Embryology, University of Zagreb School of Medicine, Šalata 3, 10000 Zagreb, Croatia, dinko.mitrecic@mef.hr.
Dražen Juraj Petrović
Paula Stančin
Jasmina Isaković
Barbara Zavan
Gerardo Tricarico
Mirjana Kujundžić Tiljak
Monica Di Luca

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A continuous rise in life expectancy has led to an increase in the number of senior citizens, now amounting to a fifth of the global population, and to a dramatic increase in the prevalence of diseases of the elderly. This review discusses the threat of dementia, a disease that imposes enormous financial burden on health systems and warrants efficient therapeutic solutions. What we learned from numerous failed clinical trials is that we have to immediately take into account two major elements: early detection of dementia, much before the onset of symptoms, and personalized (precision) medicine treatment approach. We also discuss some of the most promising therapeutic directions, including stem cells, exosomes, electromagnetic fields, and ozone.

Indexed as

DementiaAgedAgingBiomedical ResearchHumansLife ExpectancyPrecision Medicine

Identifiers

PMID32378380
PMCPMC7230408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.